Cargando…
Telmisartan Potentiates Insulin Secretion via Ion Channels, Independent of the AT1 Receptor and PPARγ
Angiotensin II type 1 (AT1) receptor blockers (ARBs), as antihypertensive drugs, have drawn attention for their benefits to individuals with diabetes and prediabetes. However, the direct effects of ARBs on insulin secretion remain unclear. In this study, we aimed to investigate the insulinotropic ef...
Autores principales: | Liu, Tao, Cui, Lijuan, Xue, Huan, Yang, Xiaohua, Liu, Mengmeng, Zhi, Linping, Yang, Huanhuan, Liu, Zhihong, Zhang, Min, Guo, Qing, He, Peifeng, Liu, Yunfeng, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477257/ https://www.ncbi.nlm.nih.gov/pubmed/34594226 http://dx.doi.org/10.3389/fphar.2021.739637 |
Ejemplares similares
-
Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist S6 Stimulates Insulin Secretion From Rat Islets
por: Yang, Xiaohua, et al.
Publicado: (2021) -
Sphingosine 1-phosphate Stimulates Insulin Secretion and Improves Cell Survival by Blocking Voltage-dependent K(+) Channels in β Cells
por: Liu, Zhihong, et al.
Publicado: (2021) -
D2-Like Receptors Mediate Dopamine-Inhibited Insulin Secretion via Ion Channels in Rat Pancreatic β-Cells
por: Liu, Mengmeng, et al.
Publicado: (2020) -
Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity
por: Ayza, Muluken Altaye, et al.
Publicado: (2020) -
Attenuation of Immune-Mediated Renal Injury by Telmisartan, an Angiotensin Receptor Blocker and a Selective PPAR-γ Activator
por: Hamano, Yuki, et al.
Publicado: (2011)